No significant difference in mutational burden, number of somatic variants, or key driver genetic mutations (PBRM1/CDKN2A) were found between the conventional and chondroid tumors, though the patients with dedifferentiated chordoma had elevated tumor mutational burdens, chromosomal abnormalities, and 9p21 deletions. The gene discussed is PBRM1; the disease is chordoma.